Skip to content
PICO Portalanswers from OpenAlex

SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy

PaperCitations, authors & open-access status

SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy is a paper indexed in PICO Portal from OpenAlex.

How many citations does SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy have?

PICO Portalcitation count

SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy has 21 citations in the OpenAlex counts PICO Portal stores.

When was SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy published?

PICO Portalyear

SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy has 2023 year in the PICO Portal index.

What is the open-access status of SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy?

PICO Portaloa status

SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy has gold oa status in the PICO Portal index.

What is the DOI of SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy?

PICO Portaldoi

The DOI for SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy is on the source record.

What is the PMID of SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy?

PICO Portalpmid

The PMID for SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy is on the source record.

What is the OpenAlex record for SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy?

PICO Portalopenalex

The OpenAlex for SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial